The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Novartis steps up coronavirus fight as part of new collaboration

Novartis CEO
Novartis CEO Vasant Narasimhan is the co-chair of the new consortium with the Gates Foundation. © Keystone / Patrick Straub

Several big pharmaceutical companies have joined forces with the Bill & Melinda Gates Foundation to scale up solutions and support health systems in response to the coronavirus pandemic.

On Thursday, Basel-based pharmaceutical giant Novartis announced that CEO Vas Narasimhan would be the co-chair of a consortium of life science companies to speed up the development and delivery of vaccines, diagnostics and treatments for Covid-19 as well as other solutions.

“We feel a deep shared responsibility to see if there are specific areas where collaboration across the life sciences industry and the Bill & Melinda Gates Foundation can accelerate solutions to this pandemic,” said Narasimhan in a statementExternal link.

More

The consortium is intended to help ramp up solutions and tap the industry’s scientific knowledge and experience in delivering products at a scale of billions per day.

As a first step, the 15 companies that are part of the consortium have agreed to share their proprietary libraries of molecular compounds with the Covid-19 Therapeutics Accelerator launched by the Gates Foundation, Wellcome, and Mastercard two weeks ago. The accelerator will screen them for potential use against Covid-19 and if there are successful hits, the compounds would move rapidly into in vivo trials in as little as two months.

Other companies that have teamed up in the consortium include GSK, Pfizer and Gilead. Gilead’s drug Remdesivir is an intravenous, antiviral medicine that is being studied in clinical trials as a treatment to Covid-19.

Last week, Novartis announced it was donating up to 130 million doses of generic hydroxychloroquine, which along with a related drug, chloroquine, is currently under evaluation in clinical trials for the treatment of Covid-19.

The company has also created a Covid-19 Response FundExternal link providing $20 million (CHF 19 million) in grants to support public health initiatives for communities affected by the pandemic.

Novartis is one of several big pharmaceutical companies that has moved out of the emerging infectious disease business. In 2014, the Swiss company sold its vaccine business to British pharma company GSK after operating at a loss for years. The company no longer has critical mass of expertise in virology, and no laboratories are working on antivirals or diagnostics.

External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Weekly top stories

Keep up to date with the best stories from SWI swissinfo.ch on a range of topics, straight into your mailbox.

Weekly

The SBC Privacy Policy provides additional information on how your data is processed.


More

Popular Stories

Most Discussed

News

Army seeks "contemporary" solution for bunker facilities

More

Swiss army looks to repurpose old bunkers

This content was published on The army is looking for a modern solution for its decommissioned fortress mortar bunkers, with plans to turn them into hardened defence hubs.

Read more: Swiss army looks to repurpose old bunkers
Women's Euro: Berne celebrates a football festival without a happy ending

More

Switzerland knocked out of Women’s Euro 2025

This content was published on Spain ended Switzerland’s run in the Women’s Euros on Friday, but fans in Bern made history with the largest supporters’ march in Women’s Euros history.

Read more: Switzerland knocked out of Women’s Euro 2025
Solar aeroplane flies around the Matterhorn

More

Solar plane flies around Matterhorn

This content was published on Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.

Read more: Solar plane flies around Matterhorn
Compulsory vaccination against cattle disease in Geneva and parts of Vaud

More

Vaccinations imposed for some Swiss cattle

This content was published on Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.

Read more: Vaccinations imposed for some Swiss cattle
Small rockfalls occurred above Brienz GR

More

Rockfalls measured above Swiss village

This content was published on A series of rockfalls occurred above the village of Brienz between 9 and 12 July. According to the municipality of Albula, the overall situation remains tense. Several people disregarded the ban on entering the area around the village.

Read more: Rockfalls measured above Swiss village
Arosa Bergbahnen with record sales

More

Arosa cable cars celebrate record year

This content was published on Arosa Bergbahnen achieved the highest figure in its 95-year history in the 2024/25 financial year with net revenue of CHF 37 million. Arosa Lenzerheide was able to capitalise on strengths such as snow reliability and the size of the ski area in a long winter season, the company announced on Thursday.

Read more: Arosa cable cars celebrate record year

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR